FDA Proposes New Rules for Tobacco Product Manufacturing

Mar.09.2023
FDA Proposes New Rules for Tobacco Product Manufacturing
The FDA proposes new rules for tobacco product manufacturing to protect public health and ensure consistency and reduce contamination.

US regulatory agency will seek input from advisory committees and the general public regarding proposed regulations.


The United States Food and Drug Administration (FDA) has proposed new requirements for the manufacturing, design, packaging, and storage of electronic cigarettes and other tobacco products. The proposed regulations aim to protect public health, minimize or prevent contamination, limit additional risks, and ensure product consistency.


The proposed regulations apply to manufacturers of both finished and bulk electronic cigarettes and other tobacco products. Under the proposed rules, finished tobacco products refer to any component or part of a tobacco product that is packaged in the final packaging, such as electronic cigarettes, cigarette packaging, or wet tobacco cans. Bulk tobacco products refer to tobacco products that are not packaged in the final packaging but are suitable for consumer use.


This proposed new regulation will be beneficial for manufacturers.


Adhere to the Federal Food, Drug and Cosmetic Act and take measures to minimize or prevent contamination in tobacco products, such as metals, glass, and plastics.


Solution to the problem of inconsistency between electronic cigarette e-liquid product labels and actual concentration.


3. Establish requirements related to identification, traceability, and correction of tobacco products that do not meet specifications or have been contaminated, including those already distributed.


If issues arise, these regulations will require manufacturers to take corrective action, which might include initiating a recall.


The proposed rules establish a framework for manufacturers to comply with, which includes:


Establish a mechanism for controlling the design and development of tobacco products.


B. Ensure that the production of finished and loose tobacco products meets established standards.


C. Aim to minimize the production and distribution of tobacco products that do not meet industry standards.


D. It is demanded that manufacturers must take appropriate measures to prevent contamination of tobacco products.


Demanding an investigation and identification of non-compliant products in order to take appropriate corrective measures such as recalling them.


Establish the ability to track all components, parts, ingredients, additives, and materials, as well as each batch of finished or loose tobacco products, in order to assist in investigating those products that do not meet the specifications.


The FDA will hold a public hearing on April 12 to collect opinions from various stakeholders, including the industry, scientific community, advocacy groups, and the public. The proposed rules will also be open for public comment for 180 days. The FDA will review all comments.


The FDA will convene a meeting of the Tobacco Products Scientific Advisory Committee (TPSAC) on May 18 to seek recommendations from external expert groups. As part of the TPSAC meeting, the public will have an opportunity to provide verbal statements. The FDA intends to publish TPSAC meeting materials on its website no later than 48 hours before the meeting begins.


2FIRSTS will conduct interviews with individuals affected by the new regulations and continue to report on the matter.


Reference:


The U.S. Food and Drug Administration (FDA) has put forward new regulations for the manufacturing of vaping products.


The Food and Drug Administration (FDA) has put forth new regulations regarding the production practices of tobacco products. These requirements aim to improve the manufacturing standards of tobacco products in order to reduce their harmful effects on consumers.


The Proposed Rule titled "Requirements for Tobacco Product Manufacturing Practice" has been introduced.


The Tobacco Products Scientific Advisory Committee (TPSAC) convened for a meeting.


Public hearing to discuss proposed regulations for tobacco product manufacturing practices.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

£600,000 of Illegal Goods Seized in West Yorkshire Raids Targeting Vape and Tobacco Laundering
£600,000 of Illegal Goods Seized in West Yorkshire Raids Targeting Vape and Tobacco Laundering
Nearly £600,000 worth of illegal goods were seized in coordinated raids across West Yorkshire as part of Operation Machinize, a nationwide crackdown targeting cash-intensive businesses suspected of laundering money through mini-markets, vape shops, and barbershops.
Nov.12 by 2FIRSTS.ai
JUUL wins approval after FDA reversal of Marketing Denial Order
JUUL wins approval after FDA reversal of Marketing Denial Order
JUUL's regulatory journey from Marketing Denial Order to approval showcases FDA's evolving approach to e-cigarette oversight.
Nov.03 by 2FIRSTS.ai
Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement
Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement
In this in-depth commentary for 2Firsts, Alan Zhao examines what Altria’s on! PLUS authorization really signals about FDA PMTA enforcement. Beyond the headline approval, FDA’s language, process design and product choices offer rare insight into how nicotine pouch regulation is taking shape—and what it means for industry compliance, in one of the earliest expert reads of the decision.
Regulations
Dec.20 by 2Firsts Perspectives
ZYN Rolls Out “X-Low” Campaign in the UK to Target Low-Strength Nicotine Pouch Market
ZYN Rolls Out “X-Low” Campaign in the UK to Target Low-Strength Nicotine Pouch Market
Philip Morris International’s (PMI) nicotine pouch brand ZYN has launched an “X-Low” low-strength campaign in the UK, accelerating its push into the ultra-low nicotine pouch segment, with updated packaging and new flavours already rolled out in both the UK and the Philippines.
Dec.09 by 2FIRSTS.ai
Philip Morris International Fails to Invalidate British American Tobacco Unit’s Vape Patent
Philip Morris International Fails to Invalidate British American Tobacco Unit’s Vape Patent
The European Patent Office’s Board of Appeal upheld British American Tobacco’s Nicoventures Trading Ltd. vape patent, rejecting Philip Morris International’s objections. The board ruled that the patent’s use of predefined heater activation parameters not based on user puffs was novel and valid.
Nov.10
Altria and NJOY Sue ITC, Claim Judge Appointment Process Is Unconstitutional
Altria and NJOY Sue ITC, Claim Judge Appointment Process Is Unconstitutional
Altria Group and its NJOY subsidiary have filed a lawsuit in Virginia federal court challenging the U.S. International Trade Commission’s process for appointing administrative law judges. The companies allege the system violates the U.S. Constitution and seek to halt an ITC patent investigation initiated by rival Juul.
Nov.10